A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality

Conditions

• Non-Small Cell Lung Cancer

Interventions

• DRUG: TQB2102 for injection
• DRUG: TQB2102 for injection combined with Benmelstobart injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.